final results of the gimema lal2317 trial: sequential chemotherapy blinatumomab for ph- b-all
Published 5 months ago • 61 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:39
an update on the gimema lal2317 trial: sequential chemotherapy blinatumomab for ph-like all
-
1:59
final analysis of the gimema lal2116 (d-alba) trial: dasatinib blinatumomab in ph b-all
-
1:22
final results of allg all08: blinatumomab with reduced intensity chemo in older adults with b-all
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
2:32
blinatumomab and ponatinib in newly diagnosed ph all: updates from a phase ii trial
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:40
an update on the gimema lal2116 trial
-
37:59
blinatumomab
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
3:04
b-all patient selection for treatment with blinatumomab
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
8:57
outcomes of sct in t-all and t-lbl
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:35
neuf: real-world data on blinatumomab for all
-
2:51
komet-008: a phase i trial of ziftomenib combinations in kmt2a-rearranged or npm1-mutant aml
-
1:37
the role of ctdna in hodgkin lymphoma
-
2:12
results from a phase i trial of tinostamustine in patients with r/r classical hl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:42
first results of the apollo trial: atra-ato versus soc in high-risk acute promyelocytic leukemia
-
3:12
go plus midostaurin and intensive chemotherapy in cbf and flt-mut aml